Champions Oncology Q4 adjusted EBITDA swings to profit of $158,000; revenue rises 12% to $13.8 million

Reuters2026/07/27 20:01

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Champions Oncology posted Q4 revenue of $13.8 million, up 12% from a year earlier, as GAAP net loss narrowed to $667,000.
GAAP operating loss tightened to $522,000; non-GAAP adjusted EBITDA swung to income of $158,000.
Oncology services margin widened 10 percentage points to 51%, on lower outsourced research services costs and continued radiopharmaceutical work brought in-house.
For fiscal 2026, revenue rose 4% to $59.4 million, while GAAP net results turned to a $1.18 million loss.
Management cited continued investment in radiopharmaceuticals, the data platform, and commercial expansion, with adjusted EBITDA positive in all four quarters.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Champions Oncology Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607271600ACCESSWRNAPR_____1196729) on July 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Champions Oncology Q4 adjusted EBITDA swings to profit of $158,000; revenue rises 12% to $13.8 million

You may also like

Crypto prices